NEW YORK (GenomeWeb News) — General Electric and Abbott have decided to scuttle their plan for GE to buy two of Abbott’s diagnostics divisions for around $8.13 billion, the firms said yesterday.
 
The companies, whose boards had approved the deal, said they were unable to agree on final terms.  
 
Abbott did not specify which “terms and conditions” killed the deal but maintained that holding the two businesses, which it said generated around $2.7 billion in 2006, will not change its earnings outlook for 2007.

To read the full story....

Register for Free.

...and receive Daily News bulletins.

Already have an account?
Login Now.

In Science this week: International Wheat Genome Sequencing Consortium publishes the bread wheat cultivar Chinese Spring reference genome, and more.

At his FDA Law Blog, Jeffrey Gibbs discusses FDA's technical assistance for the draft Diagnostic Accuracy and Innovation Act.

The New York Times reports that genetic testing has uncovered unfaithful penguins at a Utah aquarium.

Cancer researcher loses funding under new Wellcome Trust anti-bullying policies, the Guardian reports.